Drug therapy of cancer
Abrahamsen, A.F.; Brennhovd, I.O.; Host, H.; Kolstad, P.; Poppe, E.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 94(2): 106-107
1974
ISSN/ISBN: 0029-2001 PMID: 4822266 Document Number: 71247
Document emailed within 1 workday
Related Documents
Zwiebel, J. 2016: The effect on drug development of the National Cancer Institute's Cancer Therapy Evaluation Program Clinical Advances in Hematology and Oncology: H&o 14(3): 157-159Daly, P.A. 1994: Drug therapy for breast cancer Irish Medical Journal 87(5): 128; 130
Wörz, R. 1985: Drug therapy of cancer pain Medizinische Monatsschrift für Pharmazeuten 8(10): 292-300
Drings, P. 1990: Current drug therapy of bronchial cancer Verhandlungen der Deutschen Gesellschaft für Innere Medizin 96: 228-241
Castiglione, M.; Schnürch, H.G.; Bender, H.G.; Goldhirsch, A. 1994: Principles of adjuvant drug therapy in breast cancer Der Gynakologe 27(2): 49-63
Hudis, C.A.; Norton, L. 1996: Adjuvant drug therapy for operable breast cancer Seminars in Oncology 23(4): 475-493
Pfeiffer, P.; Jensen, B.V. 2005: Drug therapy of patients with metastatic colorectal cancer Ugeskrift for Laeger 167(45): 4261-4265
Bokhman, I.V.; Chepik, O.F.; Volkova, A.T.; Vishnevskiĭ, A.S. 1982: Is a cure possible for primary state-i endometrial cancer using drug therapy? Voprosy Onkologii 28(3): 34-42
Abrão, A.; Cappellano, R.S.; Possik, R.A. 1977: Palliative gastrectomy associated to drug therapy in advanced gastric cancer[ Amb: Revista da Associacao Medica Brasileira 23(6): 214-216
Vorob'ev, N.A.; Nosov, A.K.; Vorob'ev, A.V.; Moiseenko, V.M. 2010: New perspectives in the drug therapy of hormone-resistant prostate cancer Voprosy Onkologii 56(6): 645-653
Kunisawa, J.; Mayumi, T. 2001: Application of novel drug delivery system, fusogenic liposome, for cancer therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(5): 577-583
Volkov, N.M.; Moiseenko, V.M. 2007: Drug therapy for inoperable gastric cancer: current possibilities and perspectives of development Voprosy Onkologii 53(4): 383-392
Oehme, P.; Brüschke, G.; Kluchert, K.; Krüger, U. 1970: Current problems of drug therapy. 9. Stationary and ambulatory drug therapy. 2 Das Deutsche Gesundheitswesen 25(21): 957-960
Hernádi, Z.; Juhász, B.; Póka, R.; Mahunka, I.; Lampé, L. 1987: Analysis of the effectiveness and adverse effects of the drug combinations CAP and CEP in the therapy of patients in the advanced stages of ovarian cancer Orvosi Hetilap 128(47): 2457-2461
Protasov, D.A.; Zel'dovich, D.R.; Kuz'mina, L.P.; Manikhas, G.M. 1998: The role of cardioxane (ICRF-187) in the prevention of cardiotoxicity of anthracyclines in the combined drug therapy of extensive ovarian cancer Voprosy Onkologii 44(6): 718-721
Rosen, B.; Irvine, J.; Ritvo, P.; Shapiro, H.; Stewart, D.; Reynolds, K.; Robinson, G.; Thomas, J.; Neuman, J.; Murphy, J. 1997: The feasibility of assessing women's perceptions of the risks and benefits of fertility drug therapy in relation to ovarian cancer risk Fertility and Sterility 68(1): 90-94
Chekhun, V.F.; Zhylchuk, V.E.; Lukyanova, N.Y.; Vorontsova, A.L.; Kudryavets, Y.I. 2009: Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients Experimental Oncology 31(2): 123-124
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Iimori, M. 2005: Psychotherapy and drug therapy--drug therapy within the framework of psychotherapy and psychotherapy conducted during drug therapy Seishin Shinkeigaku Zasshi 107(5): 500-505
Vozeh, S. 1984: Drug level determination for optimization of drug therapy. Practical significance and new trends Schweizerische Rundschau für Medizin Praxis 73(49): 1505-1506